Bayer And Tsinghua University To Establish Research Center For Innovative Drug Discovery
This article was originally published in PharmAsia News
Executive SummaryBayer and Tsinghua University recently inaugurated the Bayer-Tsinghua University (Institute of Biomedicine) Joint Research Center for Innovative Drug Discovery in Beijing. With the goal of integrating research strengths, coordinating resources and enhancing technology cooperation, the facility is jointly formed by researchers from the university's Institute of Life Sciences and Medicine, School of Medicine and Department of Chemistry. The research center will align with international companies and actively explore research commercialization avenues to raise Tsinghua's R&D standards in drug innovation to promote medical science development. (Click here for more - Chinese Language)
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.